¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gonococcal complement fixation test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Ames test
    ¿¡ÀÓ½º°Ë»ç
  • basophil degranulation test
    È£¿°±â±¸Å»°ú¸³°Ë»ç
  • Bender Gestalt test
    º¥´õ°Ô½´Å»Æ®°Ë»ç
  • Bernstein test
    ¹ø½ºÅ¸Àΰ˻ç
  • bile solubility test
    ¾µ°³Áó¿ëÇØµµ°Ë»ç, ´ãÁó¿ëÇØµµ°Ë»ç
  • biliary drainage test
    ¾µ°³Áó¹èÃâ°Ë»ç, ´ãÁó¹èÃâ°Ë»ç
  • bactericidal test
    »ì±Õ°Ë»ç
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
  • biuret test
    ºä·¿°Ë»ç
  • blank test
    ºí·©Å©Å×½ºÆ®, °ø½ÃÇè, ´ëÁ¶½ÃÇè
  • bleeding time test
    ÃâÇ÷½Ã°£°Ë»ç
  • blood coagulation test
    Ç÷¾×ÀÀ°í°Ë»ç
  • blood sugar test
    Ç÷´ç°Ë»ç
  • blood test
    Ç÷¾×°Ë»ç
  • bone conduction test
    »ÀÀüµµ°Ë»ç, °ñÀüµµ°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • aptitude test
    Àû¼º°Ë»ç
  • arborization test
    ºÐÁö½ÃÇè
  • articulation test
    ¹ßÀ½°Ë»ç
  • artificial erection test
    Àΰø¹ß±â°Ë»ç
  • audibility test
    û·Â°Ë»ç, û·ÂÃøÁ¤
  • auditory recruitment test
    û°¢º¸Ãæ°Ë»ç
  • autoclave test sheet
    ¸ê±ÕÈ®Àΰ˻çÁö
  • autohemolysis test
    ÀÚ°¡¿ëÇ÷½ÃÇè
  • bactericidal test
    »ì±Õ½ÃÇè
  • bacteriophage neutralization test
    ¹ÚÅ׸®¿ÀÆÄÁöÁßÈ­½ÃÇè
  • balloon occlusion test
    dz¼±Æó¼â°Ë»ç
  • basic secretion test
    ±âº»ºÐºñ°Ë»ç
  • basophil degranulation test
    È£¿°±â±¸Å»°ú¸³°Ë»ç
  • bead test
    ±¸½½½ÃÇè, ±¸½½°Ë»ç
  • bile solubility test
    ´ãÁó¿ëÇØµµ°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Donath-Landsteiner test
    µµ³ª¾²¶õÆ®½ºÅ¸ÀÌ³Ê °Ë»ç
  • Draw-A-Person test(DAP)
    Àι°È­°Ë»ç
  • Du test
    Du °Ë»ç (ÁÖÀÇ : u ´Â À­Ã·ÀÚÀÓ)
  • Eleks gel-precipitin test
    ¿¤·ºÅ©ÇÑõÆòÆÇħ°­¹ý (µðÇÁÅ׸®¾Æµ¶¼Ò µ¿Á¤¹ý)
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • Farnworth D-15 test
    ÆÄ¸¥¿ö½º15»ö»ó°Ë»ç
  • Farnworth-Munsell 100 hue test
    ÆÄ¸¥¿ö½º-¹®¼¿ 100»ö»ó°Ë»ç
  • Freda test
    ÇÁ·¹´Ù½ÃÇè
  • Frei s test
    ÇÁ¶óÀ̽ÃÇè<¹ÝÀÀ>
  • Frei test
    ÇÁ¶óÀ̽ÃÇè
  • Freis test
    ÇÁ¶óÀ̰˻ç
  • Friedman test
    ÇÁ¸®µå¸¸½ÃÇè
  • Frye test
    ÇÁ¶óÀ̽ÃÇè
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Gelle test
    °Ö·¹°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • complement-mediated cytotoxicity
    º¸Ã¼ °ü·Ã¼º ¼¼Æ÷µ¶¼º(ÜÍô÷μ֤àõ á¬øàÔ¸àõ)
  • deficiency state, complement
    º¸Ã¼°áÇÌÁõ
  • dominant complement
    ¿ì¼ºº¸Ã¼(¡­ÜÍô÷).
  • endpiece of complement
    º¸Ã¼¸»Àý(ÜÍô÷ØÇï½).
  • heparin complement
    ÇìÆÄ¸°º¸Ã¼.
  • inactivation of complement
    º¸Ã¼ºñµ¿È­.
  • total hemolytic complement activity
  • alternating fixation
    ±³´ëÁÖ½Ã
  • anomalous fixation
    ÀÌ»óÁÖ½Ã
  • bifoveal fixation
    ¾ç¾ÈÁ߽ɿÍÁÖ½Ã
  • binocular fixation
    ¾ç¾ÈÁÖ½Ã(¡­ñ¼ãÊ).
  • capsular fixation
    ³¶³»°íÁ¤
  • central fixation
    Áß½ÉÁÖ½Ã
  • compensatory fixation reflex
    º¸»óÁֽùݻç
  • craniomandibular fixation
    (±¸°­¿Ü°ú)µÎ¾Ç°£°íÁ¤(µÎ¾Ç°£°íÁ¤).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • radioactive antibody test
    ¹æ»ç¼º Ç×ü ½ÃÇè(°ËÁ¤)(Û¯ÞÒàõù÷ô÷ãËúÐ(ËþïÒ))
  • resorcinol test
    ¸®Á¶¸£½Ã³î ½ÃÇè(ãËúÐ)
  • reversible boundary spreading test
    °¡¿ª °æ°è ºÐ»ê ½ÃÇè(ʦæ½ÌÑÍ£ÝÂߤãËúÐ)
  • Rice test
    ¶óÀ̽º ½ÃÇè(ãËúÐ)
  • ring test
    °í¸®½ÃÇè(ãËúÐ)
  • Rothera's test
    ·ÎÅ×¶ó ½ÃÇè(ãËúÐ)
  • Schiff's test
    ½¬ÇÁ ½ÃÇè(ãËúÐ)
  • Schilling test
    ½¯¸µ ½ÃÇè(ãËúÐ)
  • seliwanoff's test
    ¼¿¸®¹Ù³ëÇÁ ½ÃÇè(ãËúÐ)
  • SSA test
    SSA ½ÃÇè(ãËúÐ) (å²)
  • sulfosalicylic acid test
    ¼³Æ÷»ì¸®½Ç»ê(ß«)
  • Sulkowitch test
    ¼úÄÚºñÄ¡ ½ÃÇè(ãËúÐ)
  • suppression test
    ¾ï¾Ð ½ÃÇè(åääâãËúÐ)
  • test meal
    ½ÃÇè½Ä(ãËúÐãÝ)
  • thymol turbidity test
    ŸÀ̸ô ȥʵµ ½ÃÇè (ûèöúÓøãËúÐ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
GON gonococcal ophthalmia neonatorum
GU gastric ulcer; genitourinary; glucose uptake; glycogenic unit; gonococcal urethritis; gravitational ...
CCAT chick cell agglutination test; conglutinating complement absorption test
FRT Fixation Reflex Test; ¾È°ú) ½Ã¼± °íÁ¤ ¹Ý»ç Å×½ºÆ®
Bz-Ty-PABA test N-Benzoyl-L-Tyrosyl-p-Amino-Benzoic Acid test
  = Bentiromide test
  = Tr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
C3 Complement factor 3
CH 50 Complement hemolytic activity
CR Complement receptor
CR2 Complement receptor 2
CR3 Complement receptor 3
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Bekhterev's test
    º£Å©Å×·¹ºê ½ÃÇè
  • Benedict's test
    º£³×µñÆ® ½ÃÇè
  • Bernstein test
    º£¸¥½ºÅ¸ÀÎ ½ÃÇè
  • beta test
    º£Å¸ ½ÃÇè
  • bethanechol supersensitivity test
    º£Å¸³×ÄÝ °ú¹Î¹ÝÀÀ °Ë»ç
  • Bial's test
    ºñ¾Ë ½ÃÇè
  • bicarbonate titration test
    Áßź»ê¿° ÀûÁ¤ ½ÃÇè
  • Bielschowsky head-tilting test
    ºô¼î½ºÅ° µÎºÎ °æ»ç ½ÃÇè
  • bile solubility test
    ´ãÁó ¿ëÇØ ½ÃÇè
  • bilirubin test
    ºô¸®·çºó ½ÃÇè
  • binaural distorted speech test
    ¾çÀÌ¿ÖÈ­ ½ÃÇè
  • Binet's test
    ºñ³× ½ÃÇè
    ¼Ò¾Æ¿Í û³âÀÇ Á¤½Å ´É·ÂÀ» °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î, °¢Á¾ ¿¬·É¿¡¼­ÀÇ Á¤»ó ¾Æµ¿ÀÇ ´É·Â¿¡ ÀûÇÕÇϰí Ç¥ÁØÈ­µÈ ÀÏ·ÃÀÇ Áú¹®À» ÇǰËÀÚ¿¡°Ô ÇÏ¿©, ÀÌ¿¡ ´ëÇÑ ´ë´ä¿¡ µû¶ó ÇǰËÀÚÀÇ Á¤½Å ¿¬·ÉÀ» °áÁ¤ÇÏ´Â °Í.
  • Bing test
    ºù ½ÃÇè
    Áøµ¿À½Â÷¸¦ À¯¾çµ¹±â À§¿¡ ³õ°í, ûµµ¸¦ ±³´ë·Î Æó¼âÇÏ¿´´Ù°¡ °³¹æÇÏ¿´´Ù°¡ ÇÑ´Ù. ¼Ò¸®ÀÇ ³ô°í ³·À½Àº Á¤»ó ±Í¿¡¼­ ûÃëµÇ¸ç, ¶ÇÇÑ Áö°¢½Å°æ¼º û°¢½Å°æ¼º û°¢Àå¾Ö¿¡¼­µµ µé¸®³ª, Àüµµ û°¢ Àå¾Ö¿¡¼­´Â ¼Ò¸®ÀÇ Â÷À̰¡ ¾øÀÌ µé¸°´Ù.
  • biuret test
    ¹ÙÀÌÀ¯·¿ ½ÃÇè
  • blank test
    °ø½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
complement 5 The fifth component in the complement reaction sequence, probably exists in a complex with c6 and c7. It is a beta-globulin with a sedimentation coefficient of 10, serum concentration of 75 micrograms/ml and molecular weight of 180,000. It is activated by c423 and releases fragments with anaphylatoxic, chemotactic, and histamine-releasing actions and affecting smooth muscle.
(12 Dec 1998)
complement 5a <chemical> Smaller fragment formed when c5 convertase splits c5 into c5a and c5b. C5a is a 74-amino acid peptide that includes a carboxy-terminal arginine crucial for its spasmogenic activity and a carbohydrate moiety. C5a is the most potent anaphylatoxin mediating immediate hypersensitivity.
Chemical name: Complement C5a
(12 Dec 1998)
complement 5a, des-arginine Complement 5a with the carboxy-terminal arginine removed. The arginine is rapidly cleaved from the c5a fragment during complement activation by carboxypeptidase b present in normal human serum. C5a des-arg shows complete loss of spasmogenic activity though it retains some chemotactic ability.
(12 Dec 1998)
complement 6 The sixth component in the complement reaction sequence. It is a beta-globulin with a sedimentation coefficient of 8.7 and a molecular weight of 120,000 at 60 micrograms/ml in serum. It may exist in a complex with c5 and c7 and is activated by the binding of c5.
(12 Dec 1998)
complement 7 The seventh component in the complement reaction sequence. It is a beta-globulin probably in a complex with c5 and c6 and is activated by c5. The attachment of c7 renders the cell susceptible to lysis.
(12 Dec 1998)
complement 8 The next to the last essential component for cell lysis in the complement reaction sequence. It is a gamma-globulin with a molecular weight of 150,000 and a sedimentation coefficient of 8. It is present in trace amounts in serum and can be inhibited, like complement 1, by cation chelators.
(12 Dec 1998)
complement 9 The last component in the complement reaction sequence. It is an alpha-globulin present in serum as a trace, with a molecular weight of 80,000 and a sedimentation coefficient of 4.5. For cell lysis, it can be replaced by a metal chelator.
(12 Dec 1998)
complement activating enzymes <enzyme> Enzymes present in the complement system which activate one or more components in the system.
Registry number: EC 3.-
(12 Dec 1998)
complement activation The sequential activation of serum components c1 through c9, initiated by an erythrocyte-antibody complex or by microbial polysaccharides and properdin, and producing an inflammatory response.
(12 Dec 1998)
complement binding assay A test for the detection of immune complexes.
(05 Mar 2000)
complement chemotactic factor The activated complex of the fifth, sixth, and seventh components of complement (C567) which induces chemotaxis in the case of polymorphonuclear leukocytes.
(05 Mar 2000)
complement cytolysis inhibitor <protein> Vertebrate glycoprotein of uncertain function. Secreted as a 400 amino acid peptide, then cleaved to form two 200 amino acid peptides that are linked by a disulphide bridge.
Synonym: complement associated protein, complement cytolysis inhibitor, glycoprotein III.
(11 Jan 1998)
complement factor h <chemical> A beta-globulin that binds to complement 3b and makes ic3b (inactivated complement 3b) susceptible to cleavage by complement factor I. Complement factor h also acts as an alternative pathway complement inhibitor by interfering with the binding of properdin factor b to c3b.
Chemical name: Complement factor H
(12 Dec 1998)
complement factor I <enzyme> Serine proteinase that acts on ic3b (inactivated complement 3b) to cleave it into c3c and c3dg with the help of a trypsin-like proteolytic enzyme. Complement factor I was formerly called kaf, c3binf, or enzyme 3b inactivator.
Registry number: EC 3.4.21.45
(12 Dec 1998)
complement-fixing antibody Antibody that combines with and sensitises antigen leading to the activation of complement, which may result in cell lysis.
Synonym: CF antibody, sensitizing substance.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á